A federal jury in San Francisco convicted former Sanovas president & CEO Larry Gerrans this week of wire fraud and money laundering in connection with a scheme to defraud the medical device company. The jury also found Gerrans, 49, of San Anselmo, Calif., guilty of engaging in monetary transactions in criminally derived property, making false […]
Sanovas CEO Gerrans indicted on fraud, money laundering charges
A federal grand jury last week indicted Sanovas president & CEO Larry Gerrans on three counts of wire fraud and money laundering for alleged schemes to pay cash for a home and “myriad” personal expenses. Gerrans has denied the charges via a company spokesman. According to federal prosecutors and the FBI, Gerrans “employed a number of […]
Sanovas launches SteriView subsidiary aiming to fight hospital-acquired infections
Sanovas said yesterday it launched another subsidiary, SteriView, along with its SteriView instrument inspection and infection control system. The newly launched system is designed as a “front line solution” against hospital-acquired infections, Sausalito, Calif.-based Sanovas said. The system allows direct visual inspection and cleaning of hard to reach spaces on endoscopes and medical instruments. “Healthcare-acquired infections […]
Sanovas launches SinuGeniX sinus treatment subsidiary
Sanovas recently announced the launch of SinuGeniX, a wholly-owned subsidiary focused on treating chronic sinusitis with the company’s RegENT sinus treatment system. The newly-launched subsidiary won’t just supply a single tool for treating chronic sinusitis, which affects over 28 million Americans, but a suite of technologies, Sanovas CEO and system co-inventer Larry Gerrans told MassDevice.com in […]
Sanovas wins FDA 510(k) clearance for PulmoVia
Sanovas said last week that it won FDA 510(k) clearance for its PulmoVia working channel, part of its platform designed to improve diagnostic and therapeutic interventions in the lung. Working channels are normally integrated into bronchoscopes with optics as 1 piece, but the PulmoVia working channel is separate, CEO Larry Gerrans told MassDevice.com. “We took a […]
Echo Therapeutics in midst of a proxy battle with Platinum Management | Medtech personnel moves for the week of Apr. 28, 2014
Orthofix names interim CFO, taps CareFusion CFO for board | Personnel Moves
Sanovas raises $6.5M Series A1 round
Sanovas raised $6.5 million in a Series A1 round co-founder & CEO Larry Gerrans told MassDevice.com will go toward commercializing its Vas Zeppelin pulmonary device.
Sausalito, Calif.-based Sanovas closed a Series A round last summer consisting entirely of friends and family, Gerrans told us.
Sanovas CEO Gerrans goes linear with new MicroCam
In talking about his company’s newly launched MicroCam laparoscopic imaging platform, Sanovas CEO Larry Gerrans tells a story of innovation and, perhaps more importantly, of evolution.
UPDATE: Sanovas launches 1st phase of Vas Zeppelin Smart Catheter clearance push
Sanovas said it’s asked the FDA for 510(k) clearance for its Vas Zeppelin Smart Catheter, designed to diagnose and treat chronic pulmonary conditions and lung cancer.
The Sausalito, Calif.-based medical device company bills the device as "among the smallest interventional catheters," saying it’s designed to "overcome the complexity and procedural risks associated with pulmonary intervention," according to a press release.
Sanovas seeks $25 million as it gears up to go commercial
Most startup medical device companies raise 10s of millions to research and develop their products before they even get to the commercial stage. But for Sanovas and co-founder Larry Gerrans, the 12-year journey to that point required a scant $9 million – all raised from the pulmonary device firm’s founders, friends and family, Gerrans told MassDevice.com last month.
